Do the Clinical Responses and Complications Following Etanercept or Infliximab Therapy Predict Similar Outcomes with the Other Tumor Necrosis Factor-α Antagonists in Patients with Rheumatoid Arthritis? - Ang,HTS.; Helfgott,S. (J Rheumatol, 2003)